CNO Financial (CNO) AI Stock Analysis

• Market Cap: $3.92B
• Dividend Yield: 1.6%
• Average Volume (3M): 539.27K
• Price to Earnings (P/E): 14.2
• Beta (1Y): 0.71
• Revenue Growth: -1.61%
• EPS Growth: 15.79%
• Country: US
• Employees: 3,400
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Life
• EPS (TTM): 1.29
• Shares Outstanding: 96,931,930
• 10 Day Avg. Volume: 614,230
• 30 Day Avg. Volume: 539,269
• PEG Ratio: 0.17
• Price to Book (P/B): 1.58
• Price to Sales (P/S): 0.89
• P/FCF Ratio: 6.29
• Enterprise Value/Market Cap: 2.09
• Enterprise Value/Revenue: 1.85
• Enterprise Value/Gross Profit: 6.16
• Enterprise Value/Ebitda: 9.60
• 1Y Price Target: $40.00
• Price Target Upside: 1.27% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: $44.00 ▲(11.39% Upside)

CNO Financial's overall stock score is driven by strong earnings call performance and stable technical indicators. The company's moderate financial health and fair valuation also contribute positively, though high leverage and profitability challenges present risks.

Positive Factors

Revenue Growth

Exceeding revenue expectations indicates strong business model execution and market demand, supporting long-term growth prospects.

Sales Growth

Sustained sales growth in insurance products highlights effective market strategies and product appeal, enhancing future revenue stability.

Strategic Initiatives

The Bermuda treaty is expected to enhance ROE, reflecting strategic financial management and long-term profitability improvement.

Negative Factors

High Leverage

Significant leverage could strain financial flexibility and increase risk, necessitating careful debt management to ensure stability.

Profitability Challenges

Low profitability margins suggest operational inefficiencies, requiring focus on cost management to improve long-term financial health.

Impairment Charges

Significant impairment charges reflect challenges in asset valuation, potentially impacting future earnings and financial stability.

CNO Financial Business Overview & Revenue Model

Company Description

CNO Financial Group, Inc. is a leading provider of insurance and financial services in the United States, primarily serving middle-income Americans. The company operates through three main segments: Life Insurance, Health Insurance, and Annuities. CNO offers a range of products including life insurance, supplemental health insurance, and retirement solutions, catering to the needs of its diverse customer base.

How the Company Makes Money

CNO Financial generates revenue primarily through the sale of insurance products and annuities. The company earns premiums from its life and health insurance policies, which are collected regularly from policyholders. Additionally, CNO generates income from investment returns on the reserves held to back its insurance liabilities. The company also receives fees from the management of its annuity products and investment portfolios. Significant partnerships with agents and brokers enhance its distribution channels, allowing CNO to reach a wider audience. Furthermore, the company's focus on middle-income consumers often leads to stable demand for its insurance products, contributing to consistent revenue streams.

CNO Financial Financial Statement Overview

Summary

CNO Financial demonstrates moderate financial health with stable revenue growth and cash flow generation. However, profitability margins have declined, and high leverage poses potential risks. The company should focus on improving operational efficiency and managing debt levels to enhance financial stability and shareholder value.

Income Statement

CNO Financial shows moderate revenue growth with a TTM growth rate of 1.98%. The gross profit margin is stable at 38.31% in TTM, but has decreased from previous years. Net profit margin is relatively low at 6.41% in TTM, indicating room for improvement in profitability. EBIT and EBITDA margins have also declined, suggesting potential challenges in operational efficiency.

Balance Sheet

The debt-to-equity ratio is high at 1.64 in TTM, indicating significant leverage which could pose risks if not managed carefully. Return on equity has decreased to 10.97% in TTM, reflecting reduced profitability for shareholders. The equity ratio is not provided, but the high leverage suggests a need for cautious financial management.

Cash Flow

CNO Financial's free cash flow growth is positive at 5.17% in TTM, showing improvement in cash generation. The operating cash flow to net income ratio is strong at 45.45, indicating good cash conversion. The free cash flow to net income ratio remains stable at 1.0, suggesting consistent cash flow relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.44B	4.45B	4.15B	3.58B	4.12B	3.82B
Gross Profit	1.33B	1.70B	1.53B	1.79B	1.70B	1.28B
EBITDA	854.80M	1.07B	862.80M	1.20B	1.07B	757.00M
Net Income	294.70M	404.00M	276.50M	630.60M	570.30M	301.80M
Balance Sheet
Total Assets	96.70M	37.85B	35.03B	33.13B	36.20B	35.34B
Cash, Cash Equivalents and Short-Term Investments	23.30M	341.00M	22.28B	20.42B	24.91B	23.44B
Total Debt	4.30B	4.52B	4.15B	3.88B	4.00B	3.93B
Total Liabilities	403.90M	35.35B	32.81B	31.36B	30.94B	29.86B
Stockholders Equity	2.69B	2.50B	2.22B	1.77B	5.26B	5.48B
Cash Flow
Free Cash Flow	671.00M	627.70M	582.90M	495.40M	598.30M	735.50M
Operating Cash Flow	671.00M	627.70M	582.90M	495.40M	598.30M	735.50M
Investing Cash Flow	-917.70M	-1.49B	-872.30M	-1.78B	-1.53B	-608.40M
Financing Cash Flow	243.00M	1.97B	533.50M	1.20B	667.60M	210.10M

CNO Financial Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 39.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CNO, the sentiment is Positive. The current price of 39.5 is below the 20-day moving average (MA) of 39.91, below the 50-day MA of 39.66, and above the 200-day MA of 38.71, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 61.29 is Neutral, neither overbought nor oversold. The STOCH value of 53.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CNO.

CNO Financial Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FG	77 Outperform	$4.15B	9.12	10.12%	2.86%	-4.56%	―
BHF	73 Outperform	$3.77B	4.50	16.27%	―	24.80%	―
CNO	71 Outperform	$3.92B	14.16	11.12%	1.60%	-1.61%	15.79%
LNC	68 Neutral	$7.76B	3.67	21.66%	4.37%	35.76%	636.97%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
JXN	63 Neutral	$6.26B	12.74	5.50%	3.36%	24.94%	―
GNW	60 Neutral	$3.50B	19.28	―	―	1.41%	150.35%

CNO Financial Corporate Events

CNO Financial Highlights Strategic Focus in New Briefing

On September 10, 2025, CNO Financial Group issued a Consumer Division Briefing presentation, highlighting its strategic focus on middle-income households and its commitment to growth through multiple distribution channels. The briefing emphasized CNO’s differentiated ‘health and wealth’ approach, its strong market positioning, and consistent growth, with a notable increase in Medicare Advantage sales and a growing distribution force. The company aims to continue building enduring value for stakeholders and addressing the needs of an underserved market.

The most recent analyst rating on (CNO) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on CNO Financial stock, see the CNO Stock Forecast page.